Ipca Laboratories Limited Share Price and Company Fundamentals
Last traded: Today at 9:59 AM
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Key Metrics
PE ratio
41.87
PB ratio
4.62
Dividend yield
0.27%
Beta
0.21
Market cap
₹382.17B
Enterprise value
₹412.79B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 16778 |
| Website | https://www.ipca.com |
| Mailing address | 125, Kandivli Industrial Estate Kandivli (West) Mumbai 400067 India |
| Phone / Fax | 91 22 6210 5000 / 91 22 6210 5439 |
Dividends
Dividend yield
0.27%
Dividend amount
₹4.00
Payout ratio
5.58%
5Y Avg. yield
-%
Ipca Laboratories Limited paid ₹4.00 dividend and the ex-dividend date was 05 Aug 2025.The dividend payout ratio is 5.58%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.IPCALAB dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Ipca Laboratories Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Premchand Godha A.C. A., B. Com., CA | Executive Chairman | 78 | |
| Mr. Pranay Premchand Godha | CEO, MD & Executive Director | 53 | |
| Mr. Ajit Kumar Bhanwarlal Jain A.C.A., B.Sc. | CFO, MD & Executive Director | 70 | |
| Mr. Prashant Premchand Godha | Executive Director | 51 | |
| Mr. Pawan Kothari | Vice President of Operations | 60 | |
| Mr. Vishnu Saran Singh Kushwaha | Vice President of Technical | 57 | |
| Mr. Harish Pandurang Kamath | Compliance Officer, Corporate Counsel & Company Secretary | 66 | |
| Mr. Sunil Ghai | President of Marketing | 62 | |
| Mr. Saidutta Nanda | President of Human Resources | ||
| Dr. Ashok Kumar | President of R&D - Chemicals | 71 |
Profitability and management effectiveness
Profit margin
9.57%
Operating margin
17.80%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Ipca Laboratories Limited is 382.17B and its enterprise value is 412.79B. The enterprise value to revenue ratio of IPCALAB is 4.34. The enterprise value to EBITDA ratio of IPCALAB is 21.98.
The IPCALAB's stocks Beta value is 0.21 making it 79% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Ipca Laboratories Limited (NSE:IPCALAB) Frequently Asked Questions
1. What is Ipca Laboratories Limited's Stock Symbol?
Ipca Laboratories Limited trades on NSE under the ticker symbol "IPCALAB".
2. What is Ipca Laboratories Limited's stock price today?
One share of IPCALAB stock can currently be purchased for approximately ₹1500.9.
3. How can I contact Ipca Laboratories Limited?
Ipca Laboratories Limited's mailing address is 125, Kandivli Industrial Estate Kandivli (West) Mumbai 400067 India. The company can be reached via phone at 91 22 6210 5000.
4. What is Ipca Laboratories Limited's official website?
The official website of Ipca Laboratories Limited is https://www.ipca.com.